L 52/38
EN
Official Journal of the European Union
20.2.2023
ANNEX XIII
Highly Pathogenic Avian Influenza (HPAI) PART 1 SPECIFIC CONDITIONS FOR THE IMPLEMENTATION OF EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF HPAI
1.
Size of the vaccination zone: No specific conditions.
2.
Size of the peri-vaccination zone: No specific conditions.
3.
Type of vaccine to be used: Vaccines that do not contain live avian influenza virus (vaccines containing live avian influenza virus, whether attenuated or not, shall not be used).
4.
Minimum coverage: No specific conditions.
5.
Targeted animals/species: poultry or captive birds kept in the establishments included in the official vaccination plan.
PART 2 SPECIFIC CONDITIONS FOR THE REINFORCED LABORATORY SURVEILLANCE TO BE IMPLEMENTED IN THE VACCINATION AND PERI-VACCINATION ZONES DURING EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF HPAI
Laboratory surveillance by collection of samples for virological testing shall be implemented every two weeks in the establishments where emergency protective vaccination has been carried out to detect occurrence of infection with HPAI field virus.
The surveillance has to enable detection of a prevalence of infection with the HPAI virus in the vaccinated establishment of 5 % or less with a confidence level of 95 %.
PART 3 ANIMALS AND PRODUCTS SUBJECT TO PROHIBITION OF MOVEMENTS AND CONDITIONS FOR GRANTING A DEROGATION IN ACCORDANCE WITH ARTICLE 13 IN A VACCINATION ZONE WHERE EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF HPAI IS CARRIED OUT
1.
Animals and products subject to prohibition of movements: vaccinated poultry or captive birds and their products within and outside the vaccination zone.
2.
Germinal products subject to prohibition of collection: not applicable.
3.
Conditions for granting a derogation in accordance with Article 13(2), point (b)(ii), Article 13(3), point (b), and Article 13(4), point (b).
Movements of vaccinated poultry or captive birds and their products within and outside the vaccination zone may be authorised only in the cases covered by and under the same general and specific conditions as those provided for in Articles 28, 29 and 30, Article 31(1) and Articles 33, 34 and 37 of Delegated Regulation (EU) 2020/687.
After the end of the recovery period, the measures provided for in points 2 to 4 of Part 5 shall remain in place in the establishments keeping vaccinated animals, as long as they keep vaccinated animals.